Bloventus LLC 4721 Emperor Blvd., Suite 100 Durham, NC 27703 USA 1-919-474-6700 1-800-396-4325 www.BioventusGlobal.comEmployment Agreement • July 25th, 2016 • Bioventus Inc. • Surgical & medical instruments & apparatus • North Carolina
Contract Type FiledJuly 25th, 2016 Company Industry JurisdictionThis letter agreement (the “Agreement”) sets forth the terms of your continued employment at Bioventus LLC (“Bioventus” or the “Company”). This Agreement will be effective on the effective date of the initial public offering of Bioventus Inc. common stock (the “IPO”) and will supersede in its entirety that certain offer letter entered into by and between you and Bioventus LLC dated September 27, 2012.
Bioventus LLC 4721 Emperor Blvd., Suite 100 Durham, NC 27703 USA 1-919-474-0700 1-000-300-4325 www.BioventusGlobal.comEmployment Agreement • July 25th, 2016 • Bioventus Inc. • Surgical & medical instruments & apparatus • North Carolina
Contract Type FiledJuly 25th, 2016 Company Industry JurisdictionThis letter agreement (the “Agreement”) sets forth the terms of your continued employment at Bioventus LLC (“Bioventus” or the “Company”). This Agreement will be effective on the effective date of the initial public offering of Bioventus Inc. common stock (the “IPO”) and will supersede in its entirety that certain offer letter entered into by and between you and Bioventus LLC dated November 4, 2013.
Bioventus LLC 4721 Emperor Blvd., Suite 100 Durham, NC 27703 USA 1-919-474-6700 1-800-396-4325 www.BioventusGlobal.comEmployment Agreement • July 25th, 2016 • Bioventus Inc. • Surgical & medical instruments & apparatus • North Carolina
Contract Type FiledJuly 25th, 2016 Company Industry JurisdictionThis letter agreement (the “Agreement”) sets forth the terms of your continued employment at Bioventus LLC (“Bioventus” or the “Company”). This Agreement will be effective on the effective date of the initial public offering of Bioventus Inc. common stock (the “IPO”) and will supersede in its entirety that certain offer letter entered into by and between you and Bioventus LLC dated April 20, 2012.